米兰系统唾液腺细胞病理学报告在细胞病理实践中的效果:前瞻性研究的荟萃分析与回顾性研究比较
该荟萃分析纳入7项前瞻性研究和7项回顾性研究,评估米兰系统(MSRSGC)在唾液腺细针穿刺(FNA)中的效果。前瞻性研究中各诊断类别的恶性肿瘤风险(ROM)与MSRSGC参考值一致,诊断准确性在所有类别中均提高。结果表明MSRSGC在FNA细胞病理实践中运行良好。
要点
- 前瞻性研究ROM与MSRSGC参考值一致,验证了系统有效性。
- 前瞻性研究敏感性83.1%,特异性98.4%,诊断比值比310.7。
- MSRSGC提高所有诊断类别的诊断准确性。
核心结论
- MSRSGC在FNA细胞病理实践中运行良好,并提高所有诊断类别的诊断准确性。
- 前瞻性研究的ROM与MSRSGC参考值一致。
研究设计与样本
- 荟萃分析纳入7项前瞻性研究和7项回顾性研究。
- 前瞻性研究FNA总数1587例,回顾性研究1764例。
- 计算各诊断类别的恶性肿瘤风险、肿瘤风险和诊断准确性。
主要发现
- 前瞻性与回顾性研究ROM:非诊断性21.0% vs 26.6%,非肿瘤性9.4% vs 8.1%,意义不明的异型性34.9% vs 39.6%,良性肿瘤2.4% vs 2.1%,恶性潜能未定的唾液腺肿瘤36.6% vs 31.2%,可疑恶性86.0% vs 66.0%,恶性97.0% vs 96.7%。
- 前瞻性研究敏感性83.1%(95%CI 71.1%-90.8%),特异性98.4%(95%CI 96.6%-99.3%),诊断比值比310.7(95%CI 121.2-796.6)。
- 回顾性研究敏感性89.1%(95%CI 83.6%-92.9%),特异性94.9%(95%CI 91.9%-96.9%),诊断比值比218.8(95%CI 107.3-438.1)。
临床怎么用
- 在唾液腺FNA细胞病理报告中采用MSRSGC分类系统。
- 参考MSRSGC各诊断类别的ROM参考值进行临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is widely accepted and endorsed by professional societies. Although several studies focusing on the MSRSGC have been published, few have been prospective studies. The objective of this study was to evaluate the effectiveness of the MSRSGC in cytopathology practice. METHODS: A comprehensive literature search was conducted to identify all prospective studies on the MSRSGC. The risk of malignancy (ROM), risk of neoplasm, and diagnostic accuracy for each diagnostic category were calculated. Data were tabulated in Microsoft Excel, and analyses were performed with the Open Meta-Analyst program. RESULTS: Seven prospective and seven retrospective studies were identified. The total number of fine-needle aspirations (FNAs) was 1587 in the prospective studies and 1764 in the retrospective studies. The ROM values for the nondiagnostic, nonneoplastic, atypia of undetermined significance, benign neoplasm, salivary gland neoplasm of uncertain malignant potential, suspicious for malignancy, and malignant categories in prospective versus retrospective studies were 21.0% versus 26.6%, 9.4% versus 8.1%, 34.9% versus 39.6%, 2.4% versus 2.1%, 36.6% versus 31.2%, 86.0% versus 66.0%, and 97.0% versus 96.7%, respectively. Sensitivities, specificities, and diagnostic odds ratios were 83.1% (95% confidence interval [CI], 71.1%-90.8%) versus 89.1% (95% CI, 83.6%-92.9%), 98.4% (95% CI, 96.6%-99.3%) versus 94.9% (95% CI, 91.9%-96.9%), and 310.7 (95% CI, 121.2-796.6) versus 218.8 (95% CI, 107.3-438.1). CONCLUSIONS: This meta-analysis indicated that the MSRSGC works well in FNA cytopathology practice and improves diagnostic accuracy in all diagnostic categories. The ROMs of prospective studies were in concordance with the MSRSGC reference values.
引用
- Lagerstam H, Kalfert D, Maleki Z, et al. How the Milan System for Reporting Salivary Gland Cytopathology works in cytopathology practice: Meta-analysis of prospective studies and comparison with retrospective studies. Cancer Cytopathol. 2024. PMID: 38594082. doi:10.1002/cncy.22815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。